Vanguard Group Inc Immunic, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Immunic, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,931,548 shares of IMUX stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,931,548

Previous 3,923,763 0.2%

Holding current value

$3.03 Million

Previous $3.92 Million 9.23%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.94 - $1.3 $7,317 - $10,120	7,785 Added 0.2%	3,931,548 $4.29 Million
Q4 2024 Feb 11, 2025	SELL	$1.0 - $1.61 $776,253 - $1.25 Million	-776,253 Reduced 16.52%	3,923,763 $3.92 Million
Q3 2024 Nov 13, 2024	BUY	$1.08 - $1.95 $1.04 Million - $1.87 Million	959,969 Added 25.67%	4,700,016 $7.76 Million
Q2 2024 Aug 13, 2024	BUY	$0.98 - $1.44 $339,080 - $498,240	346,000 Added 10.19%	3,740,047 $4.15 Million
Q1 2024 May 10, 2024	BUY	$1.14 - $1.53 $1.94 Million - $2.61 Million	1,703,047 Added 100.71%	3,394,047 $4.48 Million
Q4 2023 Feb 14, 2024	BUY	$0.97 - $1.6 $27,558 - $45,457	28,411 Added 1.71%	1,691,000 $2.54 Million
Q3 2023 Nov 14, 2023	SELL	$1.35 - $2.87 $18,474 - $39,275	-13,685 Reduced 0.82%	1,662,589 $2.44 Million
Q2 2023 Aug 14, 2023	BUY	$1.33 - $2.51 $226,898 - $428,205	170,600 Added 11.33%	1,676,274 $4.21 Million
Q1 2023 May 15, 2023	BUY	$1.35 - $2.87 $586,242 - $1.25 Million	434,254 Added 40.53%	1,505,674 $2.24 Million
Q4 2022 Feb 10, 2023	BUY	$1.13 - $10.8 $86,726 - $828,889	76,749 Added 7.72%	1,071,420 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $346,947 - $634,913	115,649 Added 13.16%	994,671 $3.14 Million
Q2 2022 Aug 12, 2022	SELL	$3.13 - $12.25 $243,122 - $951,518	-77,675 Reduced 8.12%	879,022 $3.05 Million
Q1 2022 May 13, 2022	BUY	$9.54 - $14.26 $523,431 - $782,403	54,867 Added 6.08%	956,697 $10.8 Million
Q4 2021 Feb 14, 2022	BUY	$7.34 - $10.25 $151,387 - $211,406	20,625 Added 2.34%	901,830 $8.63 Million
Q3 2021 Nov 12, 2021	BUY	$8.05 - $13.29 $1.36 Million - $2.25 Million	169,432 Added 23.8%	881,205 $7.8 Million
Q2 2021 Aug 13, 2021	BUY	$11.76 - $16.85 $8.37 Million - $12 Million	711,773 New	711,773 $8.73 Million

Others Institutions Holding IMUX

# of Institutions

Shares Held

40.2M

Call Options Held

1.14M

Put Options Held

130K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $23.5M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Immunic, Inc. Transaction History